Chang-Hai Tsai

This inventor holds 12 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignee: China Medical University. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chang-Hai Tsai. Retrieved from https://idiyas.com/inventor/chang-hai-tsai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 1)

% Patents Active = 83.3

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 8)

Average Co-Inventor Count = 6.4

ph-index = 1

Forward Citations = 5(Granted Patents)

Company Filing History:

12 out of 110

China Medical University

patents

Years Active: 2018-2026

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12674141 - Gene-engineered mesenchymal stem cells and applications thereof (2026-07-07),

2. 12226437 - Method for enhancing expression of insulin like growth factor 1 receptor in umbilical cord mesenchymal stem cell expressing IGF1R and method for obtaining multipotent umbilical cord mesenchymal stem cell (2025-02-18),

3. 11760980 - Induced pluripotent stem cells (IPSCS) and applications thereof (2023-09-19),

4. 11529373 - Method for enhancing expression of insulin like growth factor 1 receptor in mesenchymal stem cell, method for obtaining mesenchymal stem cell, and method for treating brain tissue damage (2022-12-20),

5. 11458171 - Engineering stem cells for cancer therapy (2022-10-04),

6. 11110129 - Method for treating multiple sclerosis (2021-09-07),

7. 10988733 - Methods for obtaining pluripotent adult olfactory stem cells from an olfactory mucosa tissue (2021-04-27),

8. 10787413 - Derivatives of curcuminoids and use thereof as an anticancer agent (2020-09-29),

9. 10736964 - Immunomagnetic nanocapsule and kit for treating cancer (2020-08-11),

10. 10696945 - Methods for treating a brain tissue damage by cultured adult pluripotent olfactory stem cells (2020-06-30),

11. 10660918 - Method for enhancing insulin like growth factor 1 receptor expression of mesenchymal stem cell, method for isolating mesenchymal stem cell, and use of mesenchymal stem cell (2020-05-26),

12. 10035791 - Bicyclic compound and pharmaceutical composition thereof for treating stroke and use thereof (2018-07-31),

Title: Chang-Hai Tsai: Innovator in Stem Cell Research

Introduction

Chang-Hai Tsai is a prominent inventor based in Taichung, Taiwan. He has made significant contributions to the field of stem cell research, particularly in enhancing the expression of insulin-like growth factor 1 receptor in umbilical cord mesenchymal stem cells. With a total of 12 patents to his name, Tsai's work is paving the way for advancements in regenerative medicine.

Latest Patents

Among his latest patents is a method for enhancing the expression of insulin-like growth factor 1 receptor in umbilical cord mesenchymal stem cells. This innovative method involves culturing these cells in a medium containing platelet-derived growth factor BB (PDGF-BB) to boost the expression of the receptor. Another notable patent focuses on induced pluripotent stem cells (iPSCs), providing methods for generating somatic cells that can become iPS cells without oncogenic properties. These advancements have significant implications for transplantation and cellular differentiation.

Career Highlights

Chang-Hai Tsai is affiliated with China Medical University, where he continues to conduct research and develop new methodologies in stem cell technology. His work has garnered attention in the scientific community, contributing to the understanding and application of stem cells in medicine.

Collaborations

Tsai has collaborated with notable colleagues, including Woei-Cherng Shyu and Chen-Huan Lin. Their joint efforts have furthered research in the field and have led to innovative solutions in stem cell applications.

Conclusion

Chang-Hai Tsai's contributions to stem cell research and his innovative patents highlight his role as a leading inventor in the field. His work not only enhances scientific understanding but also opens new avenues for medical applications.

Profile summary based on public USPTO records.